Epitome Biosystems

Epitome Biosystems was a biotechnology company specializing in the development of multiplexed protein assays for drug discovery and life science research. The company's core technology, EpiTag, allowed for the quantitative measurement of protein states, including phosphorylation and other post-translational modifications, across multiple targets simultaneously. This platform provided researchers with detailed insights into cellular signaling pathways and the effects of potential drug candidates. Founded in 2002 and based in Waltham, Massachusetts, Epitome was backed by prominent venture capital firms including Flagship Pioneering and North Bridge Venture Partners. In 2008, the company was acquired by Millipore Corporation to bolster its portfolio of multiplexed assay products and expand its presence in the proteomics market.